Onaga C, Tamori S, Matsuoka I, Ozaki A, et al. High expression of SLC20A1 is less effective for endocrine therapy and predicts late recurrence in ER-positive breast cancer. PLoS One 2022;17:e0268799.
PMID: 35605014